PTPRC and sarcoidosis: We found no differences (Figure 4D) in the proportions of CD45 RA-expressing Tregs between the groups (39.40% (31.81; 48.53) in patients with sarcoidosis vs. 40.93% (28.90; 48.27) in the control group, p > 0.05).